BCR and acute lymphoblastic leukemia: It was shown previously that nuclear export inhibition suppresses downstream effects of BCR signaling in chronic lymphocytic leukemia46; therefore, it is plausible that eltanexor treatment may be effective in a subset of acute lymphoblastic leukemias relying on BCR signaling for proliferation.